1 |
C1S
💬
| 5件: Complement and coagulation cascades Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Riliprubart
Riliprubart
💬
|
Riliprubart
| 1件: 14 14 💬
|
2 |
C2
💬
| 6件: Complement and coagulation cascades Complement and coagulation cascades, Alcoholic liver disease, Pertussis, Staphylococcus aureus infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Empasiprubart
Empasiprubart
💬
|
Empasiprubart
| 2件: 14 14, 50 💬
|
3 |
C5
💬
| 11件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Alcoholic liver disease, Prion disease, Pertussis, Staphylococcus aureus infection, Herpes simplex virus 1 infection, Coronavirus disease - COVID-19, Systemic lupus erythematosus | Eculizumab
Eculizumab
💬
|
Eculizumab
| 8件: 11 11, 13, 14, 61, 62, 109, 221, 222 💬
|
4 |
HRH1
💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Inflammatory mediator regulation of TRP channels | Chlorphenamine
Chlorphenamine
💬
|
Chlorpheniramine
| 1件: 14 14 💬
|
5 |
HRH1
💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Inflammatory mediator regulation of TRP channels | Chlorpheniramine maleate
Chlorpheniramine maleate
💬
|
Chlorpheniramine
| 1件: 14 14 💬
|
6 |
KCNA4
💬
| 2件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 4件: 3 3, 4, 13, 14 💬
|
7 |
KCNC3
💬
| 1件: Spinocerebellar ataxia Spinocerebellar ataxia | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 4件: 3 3, 4, 13, 14 💬
|
8 |
KCND2
💬
| 1件: Serotonergic synapse Serotonergic synapse | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 4件: 3 3, 4, 13, 14 💬
|
9 |
KCND3
💬
| 1件: Spinocerebellar ataxia Spinocerebellar ataxia | Dalfampridine
Dalfampridine
💬
|
Dalfampridine
| 4件: 3 3, 4, 13, 14 💬
|
10 |
MS4A1
💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage | Rituximab
Rituximab
💬
|
Rituximab
| 52件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
11 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisolone
Prednisolone
💬
|
Prednisolone
| 41件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 60, 61, 63, 64, 66, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
12 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dexamethasone sodium phosphate
Dexamethasone sodium phosphate
💬
|
Dexamethasone
| 25件: 13 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
|
13 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dexamethasone phosphate
Dexamethasone phosphate
💬
|
Dexamethasone
| 25件: 13 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
|
14 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Dexamethasone
Dexamethasone
💬
|
Dexamethasone
| 25件: 13 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
|
15 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Prednisone
Prednisone
💬
|
Prednisone
| 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
16 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone
Methylprednisolone
💬
|
Methylprednisolone
| 48件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 127, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
17 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Methylprednisolone acetate
Methylprednisolone acetate
💬
|
Methylprednisolone
| 48件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 127, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
18 |
S1PR1
💬
| 4件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Efferocytosis | Fingolimod hydrochloride
Fingolimod hydrochloride
💬
|
Fingolimod
| 3件: 13 13, 14, 156 💬
|
19 |
S1PR1
💬
| 4件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Efferocytosis | Fingolimod lauryl sulfate
Fingolimod lauryl sulfate
💬
|
Fingolimod
| 3件: 13 13, 14, 156 💬
|
20 |
S1PR1
💬
| 4件: FoxO signaling pathway FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Efferocytosis | Fingolimod
Fingolimod
💬
|
Fingolimod
| 3件: 13 13, 14, 156 💬
|